Penumbra Inc at Morgan Stanley Healthcare Conference Transcript
Okay. Sorry about that, a little tough to find the room here. My name is David Lewis, Medical Device analyst from Morgan Stanley. Thanks for joining us here as we progress through the afternoon of day 2. It's my pleasure to have us here, an annual recurrence event. They've been kind to bless you with their attendance here for the last several years, even though we do not cover the company formally, but we're pleased to have Penumbra with us and both the CEO and CFO, Adam Elsesser as well as Sri Kosaraju, who's actually not just the CFO now. He is President and CFO. I almost -- almost got me.
Questions & Answers
So with that, I want to start strategically, Adam. We're here every year and I feel like the business is evolving, but the perception of the business feels very locked to where it was pre-IPO. [50%] of the business was stroke at the time of the IPO several years ago. It's 25% of the business today. Yet people remain laser-focused on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
